Markham, ON / Nashville, TN — September 16, 2026
Curait Medical is proud to announce that it was selected as a finalist in the prestigious GHIS III International Pitch Competition, held during the Global Health Innovators Summit III on September 16, 2026, at The Cannery in Nashville, Tennessee.
Presented jointly by the Global Health Connector and the Nashville Area Chamber of Commerce, the Global Health Innovators Summit connects high‑impact international healthtech companies with Nashville’s world‑renowned $100B+ healthcare ecosystem.
From a highly competitive international applicant pool of seed‑stage healthcare startups, Curait Medical was chosen to showcase its groundbreaking technology on stage before an esteemed panel of investors, health system executives, and clinical leaders. The company was presented by CEO Steven Chackowicz. Curait Medical extends its sincere appreciation to the organizers for their exceptional effort and for the opportunity to participate in this global event.
Key Event Details
Event
GHIS III International Pitch Competition (Global Health Innovators Summit III)
Date
September 16, 2026
Location
The Cannery | Nashville, Tennessee
Organizers
Global Health Connector & Nashville Area Chamber of Commerce
Presenter
Steven Chackowicz, CEO, Curait Medical
Pioneering AI in Radiation Oncology
In a fast-paced 3-minute pitch followed by live judge Q&A, Steven Chackowicz presented Curait Medical’s core vision: transforming radiation oncology through artificial intelligence.
Radiation therapy is a critical component of care required by over 50% of cancer patients worldwide, yet its underlying quality processes remain largely manual, outdated, and subjective. Curait Medical is bridging this gap with an end-to-end AI platform engineered to standardize and scale radiation therapy across the entire treatment workflow. Powered by patented AI, Curait delivers superior treatment quality, accelerated patient throughput, and meaningful cost reductions; all while seamlessly integrating with EHR systems, tracking clinical outcomes, and managing reimbursement to drive safety, operational efficiency, and clinical consistency within a single platform.
"Nashville is at the epicenter of US healthcare innovation, and being recognized among the top global healthtech innovators at GHIS III validates the vital need for our AI-quality technology," said Steven Chackowicz, CEO of Curait Medical. "We are excited to build on this momentum as we work to bring precision, safety, and scale to cancer care globally."
About Curait Medical
Curait Medical is a Toronto‑based medical technology company focused on transforming radiation treatment quality through advanced AI, automation, and clinically interpretable decision support. The company’s Complai™ platform is designed to reduce labour burden, improve treatment quality, and enhance patient access to modern adaptive radiotherapy.